Adjuvant radiation therapy for rectal cancer.

Area of Science:

• Oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Rectal cancer treatment traditionally involves surgery and radiation.
• Optimizing adjuvant therapy is crucial for improving patient outcomes.
• Combined modality treatment protocols are continuously evaluated for efficacy.

Purpose of the Study:

• To evaluate the efficacy of a combined pre- and postoperative radiation therapy protocol for rectal cancer.
• To assess the impact of adjuvant postoperative radiation on recurrence and survival rates in different disease stages.
• To determine if minimizing adjuvant therapy for early-stage rectal cancer affects survival.

Main Methods:

• A cohort of 104 rectal cancer patients received preoperative irradiation (500 rad) followed by surgery (mostly abdominal perineal resection).
• Pathological staging (Astler-Coller modification of Duke's staging) determined adjuvant treatment.
• Patients with early stages (A, B1) were observed, while those with advanced stages (B2, C1, C2) received postoperative pelvic irradiation (4500 rad).

Main Results:

• Early-stage (A, B1) patients (29) had excellent survival with no adjuvant therapy (1 recurrence, 1 death).
• Advanced-stage patients (60) showed significantly different outcomes based on postoperative radiation.
• Of 29 advanced-stage patients without postoperative radiation, 34% had pelvic recurrence and 17% distant metastasis; of 31 with postoperative radiation, only 6% had local recurrence and 13% distant metastasis.

Conclusions:

• Combined pre- and postoperative radiation therapy significantly improves survival and reduces recurrence in advanced rectal cancer.
• Minimizing adjuvant therapy for early-stage rectal cancer appears safe and does not detrimentally affect survival.
• The study highlights the critical role of postoperative radiation in managing high-risk rectal cancer patients.